Bicycle Therapeutics Plc (BCYC)
4.86
-0.29
(-5.63%)
USD |
NASDAQ |
May 07, 12:58
Bicycle Therapeutics SG&A Expense (TTM) : 75.75M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 6.375M |
| Mereo BioPharma Group Plc | 23.06M |
| NuCana Plc | 10.74M |
| DBV Technologies SA | 36.08M |
| Cellectis SA | 19.83M |